These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6130102)
1. Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenomas in vitro. Webb CB; Thominet JL; Frohman LA J Clin Endocrinol Metab; 1983 Feb; 56(2):417-9. PubMed ID: 6130102 [TBL] [Abstract][Full Text] [Related]
2. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [TBL] [Abstract][Full Text] [Related]
3. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas. Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894 [TBL] [Abstract][Full Text] [Related]
4. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line. Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion. Serri O Clin Endocrinol (Oxf); 1987 Dec; 27(6):675-82. PubMed ID: 2901301 [TBL] [Abstract][Full Text] [Related]
6. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone. Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040 [TBL] [Abstract][Full Text] [Related]
8. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas. Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604 [TBL] [Abstract][Full Text] [Related]
9. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706 [TBL] [Abstract][Full Text] [Related]
10. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas. Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713 [TBL] [Abstract][Full Text] [Related]
11. Effects of pituitary adenylate cyclase-activating polypeptide on hormone secretion by human pituitary adenomas in vitro. Desai BJ; Monson JP; Holdstock JG; Aylwin SJ; Geddes JF; Wood DF; Burrin JM J Clin Endocrinol Metab; 1994 Dec; 79(6):1771-7. PubMed ID: 7527412 [TBL] [Abstract][Full Text] [Related]
12. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas. Chang CC; Chen FW; Hsieh HC Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734 [TBL] [Abstract][Full Text] [Related]
13. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule. Bassetti M; Spada A; Arosio M; Vallar L; Brina M; Giannattasio G J Clin Endocrinol Metab; 1986 Jun; 62(6):1093-100. PubMed ID: 3084531 [TBL] [Abstract][Full Text] [Related]
14. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675 [TBL] [Abstract][Full Text] [Related]
16. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly. Lamberts SW; Verleun T; Oosterom R J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175 [TBL] [Abstract][Full Text] [Related]
17. In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas. Spada A; Sartorio A; Bassetti M; Pezzo G; Giannattasio G J Clin Endocrinol Metab; 1982 Oct; 55(4):734-40. PubMed ID: 7107817 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. Klibanski A; Alexander JM; Bikkal HA; Hsu DW; Swearingen B; Zervas NT J Clin Endocrinol Metab; 1991 Dec; 73(6):1248-55. PubMed ID: 1720125 [TBL] [Abstract][Full Text] [Related]
19. The effects of ACTH 1-17 on GH secretion in vitro. Ceda GP; Denti L; Valenti G Horm Metab Res; 1987 Aug; 19(8):361-3. PubMed ID: 2822561 [TBL] [Abstract][Full Text] [Related]
20. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly. Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]